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ABSTRACT
Background    To explore new factors that are predictive 
of post-partial nephrectomy (PN) renal global function, 
we analyzed various clinico-pathological factors with 
a special focus on renal volume measured via three-di-
mensional imaging technology and histopathological 
parameters in non-neoplastic parenchyma.
Methods    Estimated glomerular filtration rate (eGFR) 
and computed tomography (CT) scan were examined 
pre- and 6 months. post-operatively in 52 patients treated 
by PN. The post-operative percent eGFR decline was 
employed as the measure of global renal functional de-
terioration. The novel factors analyzed included the per-
cent renal parenchymal volume decline of the diseased 
side, contralateral and bilateral sides and the global 
glomerulosclerosis (GS) extent in non-neoplastic paren-
chyma. Renal parenchymal volumetry by CT scan was 
performed using SYNAPSE VINCENT (Fujifilm). Ad-
ditional factors analyzed included patient demographics 
and comorbidities, surgical factors and tumor pathology. 
All factors demonstrating significant tendencies (P < 0.1) 
in univariate analyses were subjected to multivariate lo-
gistic regression analysis.
Results    Two groups were categorized according to 
the degree of eGFR decline. Groups A and B were cate-
gorized as less than 15% and greater than 15% decline, 
respectively. Pre-operative eGFR was significantly lower 
in group B than in group A. Greater than 10% global 
GS extent in non-neoplastic parenchyma, male gender 
and proteinuria were significantly more frequent in in 
group B than in group A. The renal volume change 
was not statistically significant. In multivariate logistic 
regression analysis, greater than 10% global GS extent 
in non-neoplastic parenchyma was the sole independent 
affecting factor for Group B.
Conclusion    Our study suggested that host factors 
rather than surgical factors may be useful for the predic-
tion of post-PN renal global function. The evaluation of 
the global GS extent in non-neoplastic parenchyma is a 
promising biomarker of post-PN renal global function.
Key words    glomerulosclerosis; nephrectomy; renal 
function
The concerns after renal surgery for patients with renal 
tumors involve not only the oncological outcome but 
also the progression of chronic kidney disease (CKD). 
There is robust literature to indicate that CKD is associ-
ated with a significant increase in cardiovascular events 
and death from any cause, independent of competing 
comorbidities.1 The increased risk of CKD associated 
with radical nephrectomy (RN) combined with recent 
data highlighting the association between CKD and 
cardiovascular morbidity and mortality has motivated 
the preservation of as much normal renal parenchyma 
as possible.1, 2 When compared with the high incidence 
of post-operative CKD in RN, partial nephrectomy 
(PN) is an ideal surgical procedure that can reduce the 
probability of post-operative renal insufficiency. Sparing 
non-neoplastic renal tissue maintains long-term renal 
function in an aging population with medical comorbid-
ities.3–5 The American Urological Association guidelines 
advocate that PN is now considered the treatment of 
choice for most clinical T1 renal masses, even in those 
with a normal contralateral kidney.6 However, if the sur-
gical technique is successful, such procedure does not 
necessarily preserve the renal functions. It is important 
to predict which patients may experience significant im-
pairment after PN because they may benefit from more 
rigorous follow-up, aggressive reno-protective measures, 
and more accurate post-operative counseling. To make 
such a prediction, it is necessary to elucidate factors af-
fecting post-PN renal function. The aim of the study is 
to identify these factors that may impact post-PN renal 
global function from as many aspects as possible.
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Fig. 1. An example pre-operative volumetry image obtained by SYNAPSE VINCENT. The pink area shows the tumor area (indi-
cated by a red arrow). Other kidney shaped blue area shows normal renal parenchyma. Constructed initial image included tumor 
(A). After initial construction, tumor area was deducted (B). Then, the remaining renal normal parenchymal volumetry was per-
formed.
Fig. 2. Typical findings of global GS appearance. A rim of non-neoplastic tissue was adequate for pathological evaluation in all 
specimens. Blue arrow, renal cell carcinoma; yellow arrow, global GS; green arrow, peri-renal adipose tissue. Bar = 100 μm. GS, 
glomerulosclerosis. 
96
T. Sejima et al.
MATERIALS AND METHODS
Patients, estimated glomerular filtration rate 
(eGFR) and renal parenchymal volumetry 
A total of 78 patients were treated by PN at our institu-
tion between 2008 and 2014. The ischemic method was 
employed in all cases of PN. Among these patients, 52 
cases for which retrospective complete clinico-patholog-
ical information had been obtained were enrolled in the 
study. The study was approved by the Ethics Commit-
tee of Tottori University Faculty of Medicine (approval 
number 2692). Patient eGFR was calculated using the 
following equation: eGFR (mL/min/1.73m2) = 194 × 
serum creatinine–1.094 × Age–0.287 (for females, × 0.739).7 
This formula is currently recommended by the Japanese 
Society of Nephrology. Renal parenchymal volumetry by 
computed tomography (CT) scan was performed using 
the volume analyzer SYNAPSE VINCENT (Fujifilm, 
Tokyo, Japan). In the pre-PN renal parenchymal volume-
try of diseased side, volumetry was performed using the 
constructed renal image after deducting tumor area (Fig. 
1). Both examinations of eGFR and the CT scan were 
performed pre- and post-operatively. The examinations 
were performed within 3 months pre-operatively and 6 
months. post-operatively. 
Histopathological analysis of non-neoplastic renal 
parenchyma
A rim of non-neoplastic tissue was adequate for patho-
logical evaluation of all specimens from the 52 cases (Fig. 
2). The global glomerulosclerosis (GS) extent (%) was 
defined as the number of globally sclerotic glomeruli/the 
total number of available glomeruli × 100. The median 
(range) number of available glomeruli was 32 (20–45). 
Because the number of available glomeruli was small 
compared to that in a similar histopathological study 
using radical nephrectomy specimens,8 data analysis of 
global GS as continuous variables was considered inap-
propriate. Therefore, the categories of global GS extent 
were defined as G0 = 0%, 0% < G1 ≤ 10%, and 10% < 
G2. For the small number of cases, G0 and 1 were in-
cluded in one category (G0-1).
Group definition according to post-PN renal global 
functional decline and the analyzed factors affect-
ing post-PN renal global function
The percent eGFR decline was defined as (pre-PN 
eGFR – post-PN eGFR)/pre-PN eGFR × 100. Similarly, 
the percent renal parenchymal volume decline was de-
fined as (pre-PN volume – post-PN volume)/pre-PN vol-
Table 1. Patient and tumor characteristics in terms of the analyzed factors
Characteristics Values or number of cases
Mean (range) age (year) at PN 64.0 (32–87)
Gender Male / Female 32 / 20
Mean (range) BMI (kg/m2) 23.8 (17.5–31.2)
Mean (range) pre-PN eGFR (mL/min/1.73m2) 70.2 (21.4–106)
Mean (range) tumor diameter (cm) 2.4 (1.1–7.0)
Past history of surgical intervention to contralateral kidney Yes / No 3 / 49
Smoking history Yes / No 26 / 26
Comorbidities
HTN Yes / No 21 / 31
DM Yes / No 14 / 38
Hyperlipidemia Yes / No 11 / 41
Hyperuricemia Yes / No 5 / 47
Proteinuria Yes / No 4 / 48
Past history of CVD Yes / No 12 / 40
Surgery type Robot assisted / others 26 / 26
Ischemic method (clamping)-1 Arterial / Arterial and Venous 38 / 14
Ischemic method (clamping)-2 Total / Selective arterial 44 / 8
Mean (range) ischemic time (minute) 27.9 (8.1–80)
Tumor pathology Malignant / Benign 44 / 8
Mean (range) extent of global GS in non-neoplastic renal parenchyma (%) 5.8 (0–20.0)
Mean (range) post-PN renal parenchymal decline 
Disease side kidney (%) 5.2 (–29.9–30.2)
Contralateral kidney (%) –12.9 (–64.7–27.7)
Bilateral sides kidney (%) –3.6 (–46.3–17.7)
BMI, body mass index; CVD, cardiovascular disease; DM, diabetes mellitus; eGFR, estimated glomerular filtration rate; GS, glomerulo-
sclerosis; HTN, hypertension; PN, partial nephrectomy.
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ume × 100. The group definition according to post-PN 
renal global functional decline was as follows: Group A, 
the percent eGFR decline was less than 15; Group B, it 
was greater than 15. The analyzed factors affecting post-
PN renal global function were as follows: age; gender; 
body mass index (BMI); pre-operative eGFR; tumor 
diameter; past history of surgical intervention to contra-
lateral kidney (yes vs. no); smoking history (yes vs. no); 
comorbidities (yes vs. no) including hypertension (HTN), 
diabetes mellitus (DM), hyperlipidemia, hyperuricemia, 
proteinuria, and past history of cardiovascular disease 
(CVD); surgery type (robot assisted vs. others); ischemic 
method (arterial vs. arterial and venous clamping, total 
vs. selective arterial clamping); ischemic time; tumor 
pathology (malignant vs. benign); extent of global GS in 
non-neoplastic renal parenchyma (G2 vs. G0-1); percent 
renal parenchymal volume decline of the diseased side, 
contralateral and bilateral sides. Patient and tumor char-
acteristics in terms of the analyzed factors are listed in 
Table 1.
Statistical analyses
Statistical analyses were performed using Statview 
Version 5. To characterize unfavorable renal functional 
outcome, the analyses were focused on searching for 
affecting factors for Group B. The comparison of afore-
mentioned analyzed factors between Group A and B was 
conducted in the first step. The continuous factors were 
evaluated to determine whether the data fit a Gaussian 
distribution. If so, then paired and unpaired Student’s 
t test was used in comparison of paired and unpaired 
date, respectively; otherwise, the Mann-Whitney test 
was used. In the comparative evaluation of the nominal 
factors, the distribution of the cases was compared using 
the chi-squared test. Potent factors (P < 0.1 in univariate 
analyses) were subjected to multivariate logistic regres-
sion analysis in the second step. 
RESULTS
Comparison of pre- and post-operative eGFR and 
renal parenchymal volume
The mean (SD) pre- and post-PN (6 months. post-op-
eratively) eGFR were 70.2 (18.6) and 64.4 (20.2) mL/
min/1.73 m2, respectively. There was no significant dif-
ference between these values. However, the mean post-
PN (one week post-operatively) eGFR was 58.2 (18.8), 
and it was significantly lower than that of pre-PN eGFR 
(P = 0.0432). On the other hand, the mean (SD) pre-PN 
renal parenchymal volume of contralateral, diseased 
side, and bilaferal sides were 154.6 (42.6), 153.6 (40.6) 
and 308.2 (78.2) mL, respectively. The mean (SD) post-
PN renal parenchymal volume of contralateral, diseased 
side and bilateral sides were 173.1 (46.8), 144.6 (42.0) 
and 317.6 (80.2) mL, respectively. In comparing the con-
tralateral volume between pre- and post-PN, the post-PN 
volume was significantly higher than the pre-PN volume 
(P = 0.0381). Other comparisons (i.e., diseased side and 
bilateral sides volume between pre- and post-PN) did not 
show any significant difference.
Univariate comparison of factors between group A 
and B
Pre-PN eGFR in Group B was significantly lower than 
in Group A (P = 0.0352). The distribution of cases was 
significantly shifted toward greater than 10% global GS 
(G2) in non-neoplastic renal parenchyma (P = 0.0045), 
in male subjects (P = 0.0483) and when proteinuria was 
present (P = 0.0162) in Group B compared with Group 
A. There was a trend for the distribution of cases to be 
shifted towards past history of a surgical intervention to 
Table 2. Multivariate logistic regression analysis in searching for independent affecting factors for Group B
Factors Odds ratio (95% CI) P value
Pre-operative eGFR 0.975 0.3125
(0.928–1.024)
Extent of global GS in non-neoplastic renal parenchyma 9.149 0.0273
G2 (10% <) vs. G0-1 (≤ 10%) (1.281–65.324)
Gender 2.699 0.3112
Male vs. Female (0.395–18.442)
Proteinuria 4.082 0.3959
Yes vs. No (0.159–105.075)
Past history of surgical intervention to contralateral kidney 2.865 0.5536
Yes vs. No (0.089–92.053)
DM 0.905 0.9237
Yes vs. No (0.118–6.946)
CI, confidence interval; DM, diabetes mellitus; eGFR, estimated glomerular filtration rate; GS, glomerulosclerosis.
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the contralateral kidney (P = 0.086) and DM (P = 0.0711) 
in Group B compared with Group A.
Multivariate logistic regression analysis in search-
ing for independent affecting factors for group B
Pre-PN eGFR, extent of global GS in non-neoplastic re-
nal parenchyma (G2 vs. G0-1), gender (male vs. female), 
presence of proteinuria (yes vs. no), past history of surgi-
cal intervention to contralateral kidney (yes vs. no) and 
DM (yes vs. no) were subjected to the analysis. Greater 
than 10% global GS (G2) was the sole independent af-
fecting factor for Group B (Table 2).
DISCUSSION
Renal global function is the summation of ipsilateral 
renal function of diseased side and contralateral side. 
Although it is necessary to perform renal scintigraphy 
for the evaluation of ipsilateral renal function, this per-
formance is not feasible in clinical practice. Because our 
study is the retrospective nature and based on clinical 
practice, renal functional evaluative method was focused 
on renal global function expressed by eGFR which can 
be obtained easily and based on clinical practice. Mir et 
al. reviewed 19 articles evaluating post-PN renal global 
function in patients with bilateral kidneys and indicated 
that most series support the preservation of approxi-
mately 88% to 91% of renal global function after PN.9 
On the basis of the values, we identified the groups A 
and B. Therefore, group B (the percent eGFR decline 
was greater than 15) should be categorized unfavorable 
renal functional outcome cases. Regarding the post-PN 
period of steady renal global function, the nadir of post-
PN renal global function generally returns to the new 
steady state within three weeks after PN, as reported in 
a study using a large data set of 1,169 cases.10 Therefore, 
our check times of post-PN renal global function at 6 
month post-operatively are suitable for the elucidation of 
post-PN steady renal global function. 
 In the consideration of post-PN renal global func-
tion, it is possible to consider that based on the scheme 
(Fig. 3). In the scheme, the coefficient-1 indicates the 
ability of compensatory hypertrophy of contralateral 
kidney. Therefore, host intrinsic nature may strongly 
influence on the coefficient. On the other hand, the coef-
ficient-2 indicates the ability of recovery from the trau-
matic surgical intervention such as renal arterial clump-
ing and excision of normal renal parenchyma. Therefore, 
both of surgical factors and host intrinsic nature may 
influence on the coefficient. The ischemic time of renal 
arterial clumping is currently recognized as one of the 
most critical surgical affecting factors on post-PN renal 
function of diseased side kidney because it was shown 
that warm ischemic time greater than 25 minutes had 
indicated significantly worse renal functional outcome 
in the robust study.11 Much research has been conducted 
to identify more surgical significant factors affecting 
post-PN renal function of diseased side kidney. Simul-
taneously, the surgical technique of PN has evolved into 
a minimally invasive procedure. Robot-assisted partial 
nephrectomy (RAPN) is currently attracting attention 
as the most advanced minimally invasive surgery. How-
ever, the data supporting the superiority of RAPN com-
pared with other surgical PN procedures with regard to 
preservation of post-PN renal global function are still 
immature. Rather, patient background, such as pre-oper-
ative eGFR and HTN, significantly influences on the de-
terioration of post-PN renal global function in the com-
parative analysis between RAPN and laparoscopic PN.12 
Similarly, only age at surgery and pre-operative eGFR 
appeared to be independently related to CKD-free sur-
vival in the comparative analysis between laparoscopic 
PN and open PN.13 However, these research studies 
adopted few factors for the analysis of the influence on 
post-PN renal global function. Prior to our study, there 
has been no comprehensive analysis evaluating multiple 
factors during pre-, peri- and post-PN period. Although 
our result showing significant relationship between low 
eGFR value and Group B in a univariate analysis is in 
accordance with the aforementioned two studies,12, 13 
other significant associations of male gender and the 
presence of proteinuria to Group B have not been report-
ed previously. Moreover, our study is the first to demon-
strate that greater than 10% global GS in non-neoplastic 
renal parenchyma is the independent factor affecting the 
worsening deterioration of post-PN renal global func-
tion.
 One of the novel factors that we focused on is the 
changing of renal parenchymal volume between pre- 
and post-PN. We used the sophisticated film technology, 
SYNAPSE VINCENT, for the volumetry. Isotani et al. 
demonstrated a significant correlation between percent 
eGFR alteration and percent renal parenchymal volume 
preservation in 60 cases treated with RN using SYN-
APSE VINCENT.14 Although there was no significant 
association between renal parenchymal change and post-
PN renal global function, our study is the first to demon-
strate the significant post-PN compensatory hypertrophy 
in contralateral kidney using sophisticated film technol-
ogy, SYNAPSE VINCENT. Outside of the urological 
field, the usefulness of SYNAPSE VINCENT as the 
image-supported navigation has also been reported in 
thoracic and hepatic surgical fields.15, 16 Our finding that 
post-PN contralateral renal parenchymal volume was 
significantly larger than pre-PN volume suggests that 
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compensatory hypertrophy of the contralateral kidney 
likely occurs 6 month postoperatively. However, volu-
metric change was significantly related to none of the 
groups, A and B. The clinical research data with regard 
to compensatory hypertrophy of the contralateral kidney 
in PN is limited, except for one study in which a larger 
percent parenchymal volume loss significantly correlat-
ed with greater compensatory hypertrophy in a mixed 
patient cohort with PN and RN.17
 An association between HTN and DM and an in-
creased incidence of renal malignancy have been report-
ed in the past.18–20 Bijol et al. demonstrated a relatively 
high incidence of arterial/arteriolar sclerosis and diabetic 
GS in the histopathological analysis of nephrectomized 
non-neoplastic renal parenchyma in 110 specimens.21 
Sejima et al. also suggested that life-threatening CKD 
could be predicted by the histopathological analysis of 
non-neoplastic renal parenchyma in RN.22 The histo-
pathology of non-neoplastic renal parenchyma plays a 
pivotal role in elucidating of post-RN renal function. 
With regard to histopathological parameters in nephrec-
tomized non-neoplastic parenchyma, arteriosclerosis, in-
terstitial fibrosis/tubular atrophy and global GS were re-
ported to be the promising parameters.8, 23 Among these 
parameters, we focused on global GS, which can be 
detected easily even in a small amount of non-neoplastic 
parenchymal margin in PN. We demonstrated that great-
er than 10% global GS was the independent affecting 
factor for Group B, supporting the clinical importance 
of histopathological analysis of the non-neoplastic pa-
renchymal margin in PN. Data of histopathological anal-
ysis of non-neoplastic renal parenchyma in PN are very 
limited. There were only two studies available in which 
a significant association between interstitial fibrosis and 
pre-operative serum creatinine on one hand and percent-
age of arteriosclerosis and long-term loss of renal global 
function on the other were demonstrated.24, 25 Our study 
must be supplemented with additional studies to better 
elucidate the potent histological parameters associated 
with the post-PN renal global function. 
 Our study has certain limitations. First, our main 
result of the independent affecting factors of greater 
than 10% global GS in non-neoplastic renal parenchyma 
of PN specimen is revealed post-operatively. Because 
this finding cannot be obtained pre-operatively, post-PN 
renal global function cannot be predicted pre-operative-
ly. Therefore, once physicians obtain the unfavorable 
histopathology of non-neoplastic renal parenchyma in 
the PN specimen post-operatively, rigorous follow up, 
including medical intervention to prevent the worse out-
come related to renal functional deterioration, should be 
performed. Other limitations include the retrospective 
nature of the study and the small sample size. External 
validation of our findings and further exploration of the 
potent factors affecting post-PN renal global function 
will help to further characterize the renal functional 
change in PN.
 In conclusion, to achieve optimum tailor-made treat-
ment by PN for small renal mass throughout the pre-, 
peri- and post-operative periods, it is necessary to com-
prehensively analyze multiple factors affecting post-op-
erative renal global function. Based on the results, the 
evaluation of global GS extent in non-neoplastic paren-
chymal margin is a promising biomarker of post-PN 
renal global function. 
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